High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module
- PMID: 36082990
- PMCID: PMC9592765
- DOI: 10.1002/hep4.2070
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module
Abstract
Spleen stiffness measurement (SSM) by vibration-controlled transient elastography (VCTE) is a noninvasive technique for estimating portal hypertension in patients with chronic liver disease (CLD), with its reproducibility yet to be established and its feasibility still unknown beyond CLD. We have studied 420 participants from two tertiary referral centers for liver diseases (Novara, Milan): 297 patients with CLD (32% with cirrhosis) of different etiology (Group A), 63 Philadelphia-negative myeloproliferative neoplasms (Group B), and 60 heathy volunteers (Group C). All underwent SSM by VCTE with a spleen-dedicated module (SSM@100 Hz) and liver stiffness measurement (LSM), blindly performed by 2 different operators. In total, 1680 VCTE examinations for SSM were performed (1000 in Novara, 680 in Milan), with an overall 3.2% failure rate. Median SSM was 26.5 kPa (interquartile range [IQR] 20.0-42.3) in Group A, 26.3 kPa (IQR 22.3-33.6) in Group B, and 16.1 kPa (IQR 14.6-18.7) in Group C. In Group A, the median LSM was 6.8 kPa (IQR 4.9-11.3) in Novara and 8.3 kPa (IQR 7.1-10.8) in Milan, the proportion of patients with cirrhosis being 34% in Novara and 31% in Milan. The Group A interobserver agreement ICC was 0.90 (0.88-0.92), significantly lower in the absence of splenomegaly (ICC 0.87 vs. 0.91) and in absence of cirrhosis (ICC 0.84 vs. 0.90); overweight slightly, but not significantly reduced the interobserveragreement. The intra-observer agreement ICC ranged from 0.91 to 0.96 for the four operators. The Group B interobserver agreement ICC was 0.90 (0.83-0.94). In conclusion, SSM measured by the new spleen-dedicated VCTE module is a feasible, reliable, and highly reproducible tool in patients with CLD and hematological disorders, and in healthy volunteers.
© 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Conflict of interest statement
AP consults for and received grants from Sanofi, and consults for Incyte, Pfizer, and Novartis. MFD is on the speakers' bureau of, and received grants from, Kedrion. She advises Novartis and Gilead.
Figures
Comment in
-
Bedside spleen stiffness measurement can be reliably performed in most cases: High applicability and reproducibility using a specific 100-Hz module on vibration-controlled transient elastography.Hepatol Commun. 2022 Nov;6(11):3001-3002. doi: 10.1002/hep4.2085. Hepatol Commun. 2022. PMID: 36281032 Free PMC article. No abstract available.
References
-
- Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5‐year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140:1970–9. - PubMed
-
- Fraquelli M, Giunta M, Pozzi R, Rigamonti C, Della Valle S, Massironi S, et al. Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat. 2014;21:90–8. - PubMed
-
- Colecchia A, Montrone L, Scaioli E, Bacchi‐Reggiani ML, Colli A, Casazza G, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV‐related cirrhosis. Gastroenterology. 2012;143:646–54. - PubMed
-
- Colecchia A, Colli A, Casazza G, Mandolesi D, Schiumerini R, Reggiani LB, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV‐related cirrhosis: a prospective study. J Hepatol. 2014;60:1158–64. - PubMed
-
- Colecchia A, Marasco G, Taddia M, Montrone L, Eusebi LH, Mandolesi D, et al. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol. 2015;27:992–1001. - PubMed
